HEADER TRANSFERASE 03-APR-13 4BHL TITLE CRYSTAL STRUCTURE OF LITOPENAEUS VANNAMEI ARGININE KINASE IN BINARY TITLE 2 COMPLEX WITH ARGININE COMPND MOL_ID: 1; COMPND 2 MOLECULE: ARGININE KINASE; COMPND 3 CHAIN: A; COMPND 4 EC: 2.7.3.3 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: LITOPENAEUS VANNAMEI; SOURCE 3 ORGANISM_COMMON: PACIFIC WHITE SHRIMP; SOURCE 4 ORGANISM_TAXID: 6689; SOURCE 5 TISSUE: TAIL MUSCLE KEYWDS TRANSFERASE, BINARY COMPLEX, PHOSPHAGEN EXPDTA X-RAY DIFFRACTION AUTHOR A.A.LOPEZ-ZAVALA,K.D.GARCIA-OROZCO,J.S.CARRASCO-MIRANDA, AUTHOR 2 J.M.HERNANDEZ-FLORES,R.SUGICH-MIRANDA,E.F.VELAZQUEZ-CONTRERAS, AUTHOR 3 M.F.CRISCITIELLO,L.G.BRIEBA,E.RUDINO-PINERA,R.R.SOTELO-MUNDO REVDAT 4 20-DEC-23 4BHL 1 REMARK LINK REVDAT 3 08-MAY-19 4BHL 1 REMARK LINK REVDAT 2 27-NOV-13 4BHL 1 JRNL REVDAT 1 04-SEP-13 4BHL 0 JRNL AUTH A.A.LOPEZ-ZAVALA,K.D.GARCIA-OROZCO,J.S.CARRASCO-MIRANDA, JRNL AUTH 2 R.SUGICH-MIRANDA,E.F.VELAZQUEZ-CONTRERAS,M.F.CRISCITIELLO, JRNL AUTH 3 L.G.BRIEBA,E.RUDINO-PINERA,R.R.SOTELO-MUNDO JRNL TITL CRYSTAL STRUCTURE OF SHRIMP ARGININE KINASE IN BINARY JRNL TITL 2 COMPLEX WITH ARGININE-A MOLECULAR VIEW OF THE PHOSPHAGEN JRNL TITL 3 PRECURSOR BINDING TO THE ENZYME. JRNL REF J.BIOENERG.BIOMEMBR. V. 45 511 2013 JRNL REFN ISSN 0145-479X JRNL PMID 23873077 JRNL DOI 10.1007/S10863-013-9521-0 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.46 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.970 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 26365 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.175 REMARK 3 R VALUE (WORKING SET) : 0.172 REMARK 3 FREE R VALUE : 0.227 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1336 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 46.4751 - 4.0927 1.00 2681 124 0.2014 0.2473 REMARK 3 2 4.0927 - 3.2487 1.00 2544 135 0.1753 0.1885 REMARK 3 3 3.2487 - 2.8381 1.00 2511 126 0.1804 0.2362 REMARK 3 4 2.8381 - 2.5787 1.00 2486 148 0.1746 0.2571 REMARK 3 5 2.5787 - 2.3939 1.00 2499 125 0.1580 0.2263 REMARK 3 6 2.3939 - 2.2527 1.00 2463 124 0.1493 0.2092 REMARK 3 7 2.2527 - 2.1399 1.00 2482 136 0.1527 0.2201 REMARK 3 8 2.1399 - 2.0467 1.00 2457 143 0.1543 0.2259 REMARK 3 9 2.0467 - 1.9680 1.00 2465 132 0.1550 0.2418 REMARK 3 10 1.9680 - 1.9000 1.00 2441 143 0.1625 0.2382 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 0.90 REMARK 3 SHRINKAGE RADIUS : 0.60 REMARK 3 K_SOL : 0.41 REMARK 3 B_SOL : 51.96 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.200 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 18.620 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 14.29 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 16.30 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.97120 REMARK 3 B22 (A**2) : -0.03980 REMARK 3 B33 (A**2) : -0.93140 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 2900 REMARK 3 ANGLE : 1.043 3923 REMARK 3 CHIRALITY : 0.066 425 REMARK 3 PLANARITY : 0.005 520 REMARK 3 DIHEDRAL : 14.471 1093 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: RESIDUES 312-319 ARE DISORDERED AND REMARK 3 WERE NOT INCLUDED IN THE FINAL MODEL. REMARK 4 REMARK 4 4BHL COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 03-APR-13. REMARK 100 THE DEPOSITION ID IS D_1290056293. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-JUL-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X6A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9795 REMARK 200 MONOCHROMATOR : SI(111) CHANNEL CUT REMARK 200 OPTICS : 1M LONG RH COATED TOROIDAL REMARK 200 MIRROR FOR VERTICAL AND REMARK 200 HORIZONTAL FOCUSING REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 270 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 26516 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 19.100 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 7.100 REMARK 200 R MERGE (I) : 0.06000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 22.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.01 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.1 REMARK 200 DATA REDUNDANCY IN SHELL : 6.90 REMARK 200 R MERGE FOR SHELL (I) : 0.21000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 5.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 4AM1 REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.50 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.03 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN WAS CRYSTALLIZED FROM 0.2 M REMARK 280 SODIUM ACETATE, 0.1 M SODIUM CACODYLATE PH 6.5 AND 30 % (W/V) REMARK 280 PEG 8000 USING THE MICROBATCH METHOD REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 28.18400 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 41.02700 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.16900 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 41.02700 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 28.18400 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 35.16900 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ARG A 312 REMARK 465 GLY A 313 REMARK 465 GLU A 314 REMARK 465 HIS A 315 REMARK 465 THR A 316 REMARK 465 GLU A 317 REMARK 465 ALA A 318 REMARK 465 GLU A 319 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 MET A 1 CB CG SD CE REMARK 470 LYS A 94 CG CD CE NZ REMARK 470 LYS A 286 CG CD CE NZ REMARK 470 ASN A 293 CG OD1 ND2 REMARK 470 GLU A 295 CG CD OE1 OE2 REMARK 470 LYS A 296 CG CD CE NZ REMARK 470 ARG A 309 CG CD NE CZ NH1 NH2 REMARK 470 THR A 311 CB OG1 CG2 REMARK 470 LYS A 351 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 114 71.43 -156.26 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2160 DISTANCE = 6.52 ANGSTROMS REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 BETA-MERCAPTOETHANOL (BME): BETA-MERCAPTOETHANOL IS REMARK 600 COVALENTLY BOUNDED TO CYS 139. REMARK 600 ARGININE (ARG): ARGININE IS A SUBSTRATE FOR THE ENZYME REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ARG A 400 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BME A 401 DBREF 4BHL A 1 356 UNP Q004B5 Q004B5_LITVA 1 356 SEQADV 4BHL MET A 131 UNP Q004B5 LEU 131 CONFLICT SEQADV 4BHL GLU A 294 UNP Q004B5 ARG 294 CONFLICT SEQADV 4BHL GLU A 343 UNP Q004B5 GLN 343 CONFLICT SEQRES 1 A 356 MET ALA ASP ALA ALA VAL ILE GLU LYS LEU GLU ALA GLY SEQRES 2 A 356 PHE LYS LYS LEU GLU ALA ALA THR ASP CYS LYS SER LEU SEQRES 3 A 356 LEU LYS LYS TYR LEU THR LYS GLU VAL PHE ASP LYS LEU SEQRES 4 A 356 LYS ASP LYS ARG THR SER LEU GLY ALA THR LEU LEU ASP SEQRES 5 A 356 VAL ILE GLN SER GLY VAL GLU ASN LEU ASP SER GLY VAL SEQRES 6 A 356 GLY ILE TYR ALA PRO ASP ALA GLU ALA TYR THR LEU PHE SEQRES 7 A 356 ALA PRO LEU PHE ASP PRO ILE ILE GLU ASP TYR HIS VAL SEQRES 8 A 356 GLY PHE LYS GLN THR ASP LYS HIS PRO ASN LYS ASP PHE SEQRES 9 A 356 GLY ASP VAL ASN SER PHE VAL ASN VAL ASP PRO GLU GLY SEQRES 10 A 356 LYS PHE VAL ILE SER THR ARG VAL ARG CYS GLY ARG SER SEQRES 11 A 356 MET GLN GLY TYR PRO PHE ASN PRO CYS LEU THR GLU SER SEQRES 12 A 356 GLN TYR LYS GLU MET GLU ALA LYS VAL SER SER THR LEU SEQRES 13 A 356 SER SER LEU GLU GLY GLU LEU LYS GLY THR TYR TYR PRO SEQRES 14 A 356 LEU THR GLY MET SER LYS GLU VAL GLN GLN LYS LEU ILE SEQRES 15 A 356 ASP ASP HIS PHE LEU PHE LYS GLU GLY ASP ARG PHE LEU SEQRES 16 A 356 GLN ALA ALA ASN ALA CYS ARG TYR TRP PRO ALA GLY ARG SEQRES 17 A 356 GLY ILE TYR HIS ASN ASP ASN LYS THR PHE LEU VAL TRP SEQRES 18 A 356 VAL ASN GLU GLU ASP HIS LEU ARG ILE ILE SER MET GLN SEQRES 19 A 356 MET GLY GLY ASP LEU GLY GLN VAL PHE ARG ARG LEU THR SEQRES 20 A 356 SER ALA VAL ASN GLU ILE GLU LYS ARG ILE PRO PHE SER SEQRES 21 A 356 HIS HIS ASP ARG LEU GLY PHE LEU THR PHE CYS PRO THR SEQRES 22 A 356 ASN LEU GLY THR THR VAL ARG ALA SER VAL HIS ILE LYS SEQRES 23 A 356 LEU PRO LYS LEU ALA ALA ASN GLU GLU LYS LEU GLU GLU SEQRES 24 A 356 VAL ALA GLY LYS TYR ASN LEU GLN VAL ARG GLY THR ARG SEQRES 25 A 356 GLY GLU HIS THR GLU ALA GLU GLY GLY ILE TYR ASP ILE SEQRES 26 A 356 SER ASN LYS ARG ARG MET GLY LEU THR GLU PHE GLN ALA SEQRES 27 A 356 VAL LYS GLU MET GLU ASP GLY ILE LEU GLU LEU ILE LYS SEQRES 28 A 356 ILE GLU LYS GLU MET HET ARG A 400 12 HET BME A 401 4 HETNAM ARG ARGININE HETNAM BME BETA-MERCAPTOETHANOL FORMUL 2 ARG C6 H15 N4 O2 1+ FORMUL 3 BME C2 H6 O S FORMUL 4 HOH *291(H2 O) HELIX 1 1 ASP A 3 ALA A 20 1 18 HELIX 2 2 SER A 25 LEU A 31 1 7 HELIX 3 3 THR A 32 LYS A 40 1 9 HELIX 4 4 THR A 49 ASN A 60 1 12 HELIX 5 5 ASP A 71 PHE A 78 1 8 HELIX 6 6 PHE A 78 HIS A 90 1 13 HELIX 7 7 ASP A 106 PHE A 110 5 5 HELIX 8 8 PHE A 136 LEU A 140 5 5 HELIX 9 9 THR A 141 SER A 158 1 18 HELIX 10 10 GLU A 160 LEU A 163 5 4 HELIX 11 11 SER A 174 ASP A 184 1 11 HELIX 12 12 ASP A 192 ALA A 197 1 6 HELIX 13 13 ASP A 238 ILE A 257 1 20 HELIX 14 14 CYS A 271 LEU A 275 5 5 HELIX 15 15 LYS A 289 ALA A 292 5 4 HELIX 16 16 ASN A 293 TYR A 304 1 12 HELIX 17 17 THR A 334 MET A 356 1 23 SHEET 1 AA 8 GLY A 165 PRO A 169 0 SHEET 2 AA 8 GLY A 209 ASN A 213 -1 O ILE A 210 N TYR A 168 SHEET 3 AA 8 PHE A 218 VAL A 222 -1 O PHE A 218 N ASN A 213 SHEET 4 AA 8 LEU A 228 MET A 235 -1 O ARG A 229 N TRP A 221 SHEET 5 AA 8 VAL A 120 ARG A 129 -1 O THR A 123 N GLN A 234 SHEET 6 AA 8 ARG A 280 LYS A 286 -1 O ARG A 280 N ARG A 126 SHEET 7 AA 8 ILE A 322 ASN A 327 -1 O TYR A 323 N ILE A 285 SHEET 8 AA 8 LEU A 306 ARG A 309 -1 O GLN A 307 N SER A 326 SHEET 1 AB 2 HIS A 261 HIS A 262 0 SHEET 2 AB 2 GLY A 266 PHE A 267 -1 O GLY A 266 N HIS A 262 LINK SG CYS A 139 S2 BME A 401 1555 1555 2.03 CISPEP 1 TRP A 204 PRO A 205 0 4.59 SITE 1 AC1 11 SER A 63 GLY A 64 VAL A 65 GLY A 66 SITE 2 AC1 11 TYR A 68 GLU A 225 CYS A 271 HOH A2069 SITE 3 AC1 11 HOH A2078 HOH A2290 HOH A2291 SITE 1 AC2 4 PRO A 138 CYS A 139 LYS A 303 HOH A2060 CRYST1 56.368 70.338 82.054 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017741 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014217 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012187 0.00000